4.10
price down icon2.15%   -0.09
after-market Handel nachbörslich: 4.08 -0.02 -0.49%
loading

Finanzdaten der Omeros Corporation-Aktie (OMER)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Selling, General, and Administrative
6.99%
10.35
11.12 12.34 11.32 13.81
Costs And Expenses
7.48%
32.35
34.97 35.66 35.41 59.16
Operating Income/Loss
7.48%
-32.35
-34.97 -35.66 -35.41 -59.16
Income/Loss From Continuing Operations Before Tax
22.63%
-25.89
-33.46 -23.17 -37.11 -56.04
Income/Loss From Continuing Operations After Tax
31.08%
-25.89
-37.56 -36.54 -37.11 -65.12
Income/Loss From Discontinued Operations, Net Of Tax
88.65%
0.466
4.105 5.183 4.881 9.084
Net Income/Loss
24.02%
-25.42
-33.46 -31.36 -32.23 -56.04
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.91%
58.59
58.06 -0.0611 57.95 57.94
Basic Earnings Per Share
25.86%
-0.43
-0.58 -0.55 -0.56 -0.97
Diluted Earnings Per Share
25.86%
-0.43
-0.58 - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$21.75
price down icon 5.15%
$85.96
price up icon 1.45%
$32.75
price up icon 0.21%
$102.61
price up icon 0.30%
$161.38
price down icon 1.56%
biotechnology ONC
$320.94
price down icon 1.86%
Kapitalisierung:     |  Volumen (24h):